Showing results (101-110 of 227) with videos related to
Sort By:
Pageof 23
General Psychiatry|January 11, 2020
Very early family-based intervention for anxiety: two case studies with toddlersDina R Hirshfeld-Becker, Aude Henin, Stephanie J Rapoport, et al.Behavioral and Brain Functions : BBF|June 17, 2008
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHDTimothy E Wilens, Thorsten Klint, Lenard Adler, et al.Journal of Child and Adolescent Psychopharmacology|November 3, 2005
The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?Timothy E Wilens, Michael C Monuteaux, Lindsey E Snyder, et al.Journal of Psychiatric Research|November 12, 2016
Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysisAmy M Yule, MaryKate Martelon, Stephen V Faraone, et al.Substance Use & Addiction Journal|January 23, 2024
Is Early Onset of Nonmedical Prescription Stimulant Use Associated With Cocaine Use During Adolescence? Results From a National StudySean Esteban McCabe, Ty S Schepis, John E Schulenberg, et al.Psychiatric Services (Washington, D.C.)|October 4, 2023
Trends in Attention-Deficit Hyperactivity Disorder Diagnosis and Pharmacotherapy Among Adults With Opioid Use DisorderTae Woo Park, Tithi D Baul, Jake R Morgan, et al.Journal of Child and Adolescent Psychopharmacology|December 29, 2005
An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorderTimothy E Wilens, James Waxmonsky, Megan Scott, et al.The American Journal of Psychiatry|March 5, 2008
Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up studyJoseph Biederman, Michael C Monuteaux, Thomas Spencer, et al.Journal of Child and Adolescent Psychopharmacology|June 14, 2006
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorderJames J McGough, Keith McBurnett, Oscar Bukstein, et al.Journal of Child and Adolescent Psychopharmacology|November 3, 2005
Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disordersRamon Solhkhah, Timothy E Wilens, Jeanine Daly, et al.Pageof 23